BioSpace News Archive

LUNGevity expands its Scientific Advisory Board with two Career Development Awardees to deepen expertise in areas key to LUNGevity’s research program

Ampio Pharmaceuticals, Inc., announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Apollo Endosurgery, Inc. announced that company management is scheduled to present at the JMP Securities 2019 Life Sciences Conference being held June 19-20, 2019 at the St. Regis New York.

Before an audience of 200 technology and civic leaders at Boston’s Seaport Hotel, the Massachusetts High Technology Council honored University of Massachusetts at Lowell Chancellor Jacqueline Moloney with its Ray Stata Leadership and Innovation Award, and hosted Governor Charlie Baker and Congressman Joseph P. Kennedy, III at its 2019 Annual Meeting on June 10.

The National Kidney Foundation has launched Kidney Pathways, an interactive education platform that uses an online kidney health assessment tool to provide a curated learning pathway for people at any stage of chronic kidney disease.

First and only once-daily, nebulized bronchodilator has potential to address unmet needs of China’s nearly 100 million chronic obstructive pulmonary disease (COPD) patients [14-June-2019] DUBLIN and HERTFORDSHIRE, England and PITTSBURGH , June 14, 2019 /PRNewswire/ -- Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) (

The global anaplastic thyroid cancer drugs market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by Technavio.

In order for the Company to achieve quorum, the Company’s board of directors and management respectfully requests all such holders as of the record date to please vote their proxies as soon as possible, but no later than July 1, 2019 at 11:59 pm ET.

First and only once-daily, nebulized bronchodilator has potential to address unmet needs of China’s nearly 100 million chronic obstructive pulmonary disease (COPD) patients [14-June-2019] DUBLIN and HERTFORDSHIRE, England and PITTSBURGH , June 14, 2019 /PRNewswire/ -- Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) (

Flatiron Health today announced that Dr. Michael Vasconcelles, a practicing oncologist and senior biotechnology and pharmaceutical executive, has joined as Chief Medical Officer, effective August 2019